Literature DB >> 5695686

[On the problem of hemostyptic effect of estriolsuccinate within the scope of anticoagulant therapy using coumarin derivatives].

E Halberstadt, E Hentschel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5695686     DOI: 10.1007/bf00668730

Source DB:  PubMed          Journal:  Arch Gynakol        ISSN: 0003-9128


× No keyword cloud information.
  44 in total

1.  [Anticoagulants].

Authors:  H H BORGER
Journal:  Ther Ggw       Date:  1963-06

2.  SURGICAL BLOOD LOSS AND PREOPERATIVE ESTROGEN IN THE PREMENOPAUSAL PATIENT.

Authors:  C W NICKERSON; J H LEE
Journal:  Obstet Gynecol       Date:  1965-09       Impact factor: 7.661

3.  Oestriol succinate as a haemostyptic agent.

Authors:  R HEIKINHEIMO; J L KALLIOMAKI
Journal:  Curr Ther Res Clin Exp       Date:  1963-03

4.  [Intravenous promarit as a hemostatic agent].

Authors:  I M NILSSON
Journal:  Nord Med       Date:  1960-09-22

5.  The use of premarin IV in hemoptysis.

Authors:  J POPPER
Journal:  Dis Chest       Date:  1960-06

6.  The failure of intravenous estrogens (premarin) to affect plasma clotting factors in humans.

Authors:  H G KUDISH; S I RAPAPORT
Journal:  J Urol       Date:  1960-05       Impact factor: 7.450

7.  Changes in plasma prothrombin, Ac-globulin, and antithrombin concentration following intravenous administration of estrogens.

Authors:  J F JOHNSON
Journal:  Proc Soc Exp Biol Med       Date:  1957-01

8.  [On the effect of dicumarol on capillary permeability].

Authors:  P MATIS; H HAGER
Journal:  Z Gesamte Exp Med       Date:  1951

9.  [Variations in permeability, independent of variations in prothrombin time, produced by dicumarol].

Authors:  G KUSCHINSKY; H LUDEWIG
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1950
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.